AT140267T
Method of screening for protein inhibitors and activators
Abstract
The method is applicable in the medical field. Protein inhibitors and activators have been identified, the expression of which affects the phenotypic characteristics of the cell and, in particular, the cultural or morphological characteristics. Use their stronger influence on cells to produce protein compared to cells that produce little or no protein at all. In the preferred embodiment, the effect is observed with the naked eye. The method identifies tamoxifen as an inhibitor of px activity in cell culture.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
47 members in 18 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 15420688 | United States of America | A |
Members47
| Document | Office | Kind | |
|---|---|---|---|
| IE890398L | Ireland | L | |
| WO8907654A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3184089A | Australia | A | |
| IL89227A0 | Israel | A0 | |
| IL89227D0 | Israel | D0 | |
| ES2010131A6 | Spain | A6 | |
| FI903918A0 | Finland | A0 | |
| NO903494D0 | Norway | D0 | |
| DK189590D0 | Denmark | D0 | |
| NO20021142L | Norway | L | |
| NO903494L | Norway | L | |
| DK189590A | Denmark | A | |
| US4980281A | United States of America | A | |
| EP0403506A1 | European Patent Office (EPO) | A1 | |
| WO9102085A1 | World Intellectual Property Organization (WIPO) | A1 | |
| IE902899A1 | Ireland | A1 | |
| AU6427190A | Australia | A | |
| HUT55447A | Hungary | A | |
| IL95368A0 | Israel | A0 | |
| IL95368D0 | Israel | D0 | |
| AU612948B2 | Australia | B2 | |
| EP0403506A4 | European Patent Office (EPO) | A4 | |
| JPH03503598A | Japan | A | |
| EP0486619A1 | European Patent Office (EPO) | A1 | |
| EP0486619A4 | European Patent Office (EPO) | A4 | |
| MX165993B | Mexico | B | |
| JPH05503419A | Japan | A | |
| HU208555B | Hungary | B | |
| US5266464A | United States of America | A | |
| BG60325B2 | Bulgaria | B2 | |
| CA1334927C | Canada | C | |
| IL89227A | Israel | A | |
| EP0403506B1 | European Patent Office (EPO) | B1 | |
| AT140267TThis record | Austria | T | |
| ATE140267T1 | Austria | T1 | |
| DE68926816D1 | Germany | D1 | |
| DE68926816T2 | Germany | T2 | |
| US5688655A | United States of America | A | |
| IE77332B1 | Ireland | B1 | |
| FI102618B | Finland | B | |
| FI102618B1 | Finland | B1 | |
| US5877007A | United States of America | A | |
| DK200100720A | Denmark | A | |
| NO20021142D0 | Norway | D0 | |
| NO313103B1 | Norway | B1 | |
| RO118452B1 | Romania | B1 | |
| US2006019329A1 | United States of America | A1 |
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent revokedRevokedRZN | RZN | |
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 89902686
Titles2
- German
- SCREENING-VERFAHREN FÜR PROTEIN-INHIBITOREN UND - AKTIVATOREN.
- English
- SCREENING PROCEDURE FOR PROTEIN INHIBITORS AND ACTIVATORS.
Classification
- CPC, 7
- G01N33/5011
- C12N9/12
- G01N33/5008
- G01N33/5017
- G01N33/502
- G01N33/5023
- G01N33/5026
- IPC, 5
- C12N15 09
- C12N9 12
- C12Q1 00
- C12Q1 02
- G01N33 50